Blaine Davis, Chief Financial Officer at Cartesian Therapeutics, Inc. (RNAC), sold 15,978 shares at $16.83 ($268K) on 2025-01-06, disclosed to the SEC on 2025-01-07.
Open-market sale of $268k RNAC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.72 | 3,961 | $66K | 24.7% |
| 2 | $16.72 | 3,961 | $66K | 24.7% |
| 3 | $16.83 | 4,028 | $68K | 25.3% |
| 4 | $16.83 | 4,028 | $68K | 25.3% |
| Total | $16.78 avg | 15,978 | $268K | 100% |
| Filing → |